Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of antidiabetic agents. It plays a significant role in the preparation of DPP-4 inhibitors, which are used to manage type 2 diabetes by enhancing insulin release and reducing glucose production. Its fluorinated structure improves metabolic stability and bioavailability in final drug forms. Also employed in medicinal chemistry research for designing enzyme inhibitors due to its ability to mimic carboxylic acid groups while offering enhanced lipophilicity and resistance to degradation.